21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
High affinity VEGF-receptor antagonists
#13802PHOSPHATE BUFFERED OPHTHALMIC SOLUTIONS DISPLAYING IMPROVED EFFICACY
#13803Inhibition of proliferation and fibrotic response of activated corneal stromal cells
#13804Pharmaceutical compositions of HDAC inhibitors and chelatable metal compounds, and metal-HDAC inhibitors chelate complexes
#13805Oral Composition with an Antiageing Effect on the Skin
#13806Nutraceutical composition and methods for its use
#13807Topiramate Compositions and Methods of Making and Using the Same
#13808Statin and Omega-3 Fatty Acids For Lipid Therapy
#13809METHODS FOR THE TREATMENT OF PSORIASIS OR PSORIATIC ARTHRITIS USING CYCLOPROPYL-N-CARBOXAMIDE
#13810Phosphorus binder for treatment of renal disease
#13811QUININE AND QUINIDINE SALTS, METHODS FOR MAKING THEM, AND PHARMACEUTICAL FORMULATIONS COMPRISING THEM
#13812Combinations of Flibanserin with Caffeine, Process for Their Preparation and Use Thereof as Medicaments
#13813COMBINATIONS OF MONOAMINE REUPTAKE INHIBITORS AND POTASSIUM CHANNEL ACTIVATORS
#13814COMBINATIONS OF (A) AN ATP-COMPETITIVE INHIBITOR OF C-ABL KINASE ACTIVITY WITH (B) TWO OR MORE OTHER ANTINEOPLASTIC AGENTS
#13815Kinase modulating compounds and uses thereof for treatment of cancer
#13816ACE INHIBITOR-VASOPRESSIN ANTAGONIST COMBINATIONS
#13817STABILIZATION OF GLUCOCORTICOID ESTERS WITH ACIDS
#13818Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application
#13819Compositions and methods for reducing hepatotoxicity associated with drug administration and treating non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and associated cirrhosis
#13820Treatment of viral infections by modulation of host cell metabolic pathways
#13821Compositions and methods for the regulation of homocysteine levels within the body
#13822Multi-carotenoids compositions and uses therefor
#13823ORGANIC THIOPHOSPHATE ANTIRETROVIRAL AGENTS
#13824SYNERGISTIC EFFECTS OF COMBINED ADMINISTRATION OF MIRTAZAPINE AND A STIMULANT COMPOUND
#13825OPHTHALMIC SOLUTIONS DISPLAYING IMPROVED EFFICACY
#13826GENE DETECTION ASSAY FOR IMPROVING THE LIKELIHOOD OF AN EFFECTIVE RESPONSE TO AN EGFR ANTAGONIST CANCER THERAPY
#13827Methods of inhibiting growth of bacteria, yeast, fungus, and virus with and extracellular products
#13828INFLAMMATION REDUCING ACTION OF SYNERGISTIC MIXTURES OF BISABOLOL AND GINGER EXTRACTS
#13829Chinese medicine composition and preparation method and use thereof
#13830METHOD OF INHIBITING THE PROLIFERATION AND MIGRATION OF HELICOBACTOR PYLORI
#13831Compositions and methods for diagnosing and treating melanoma
#13832NUTRITIONAL AND/OR PHARMACEUTICAL PREPARATION FOR USE IN PROPHYLAXIS AND TREATMENT OF DISTURBANCES IN MICROELEMENTS ABSORPTION FROM THE ALIMENTARY CANAL
#13833DELIVERY SCAFFOLDS AND RELATED METHODS OF USE
#13834Chlorine dioxide releasing composite article
#13835METHODS FOR CONTROLLING INTRACELLULAR CALCIUM LEVELS ASSOCIATED WITH AN ISCHEMIC EVENT
#13836ANTI-MAdCAM ANTIBODY COMPOSITIONS
#13837Induction of antigen specific immunnologic tolerance
#13838Methods and compositions for increasing RNA interference
#13839Preparation for treatment of non-infectious inflammatory intestinal diseases
#13840SUPPRESSION OF POSTOPERATIVE ILEUS
#13841Modified erythropoietin polypeptides and uses thereof for treatment
#13842Use of Morpholino Compounds for the Treatment of Halitosis
#13843Organic compounds
#13844DIAGNOSTIC THERAPEUTIC METHOD
#13845T type calcium channel inhibitors
#13846Non-Standard Amino Acid Conjugates of Amphetamine and Processes for Making and Using the Same
#13847TREATING SKIN DISORDERS
#13848Pharmaceutical compositions having desirable bioavailability
#13849Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#13850PHARMACEUTICAL COMPOSITIONS HAVING DESIRABLE BIOAVAILABILITY
#13851AVERMECTIN/BENZOYL PEROXIDE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA
#13852Use of drug combinations for treating insulin resistance
#13853Method of Treating Atherosclerosis, dyslipidemias and related conditions
#13854EPOTHILONE DERIVATIVES FOR THE TREATMENT OF MULTIPLE MYELOMA
#13855COMBINED NSAID AND ACID BLOCKER FORMULATION AND METHOD
#13856Parenteral solutions containing metolazone
#13857TREATMENT OF AMM
#13858Composition for treatment of nail infections
#13859COMBINATIONS COMPRISING BCR-ABL/C-KIT/PDGF-R TK INHIBITORS FOR TREATING CANCER
#13860Pharmaceutical Compositions Comprising Simvastatin and Ezetimibe
#13861TREATMENT OF DISEASE CONDITIONS THROUGH MODULATION OF HYDROGEN SULFIDE PRODUCED BY SMALL INTESTINAL BACTERIAL OVERGROWTH
#13862Compositions and Methods for Fat Reduction
#13863Methods and Compositions for the Treatment of Gastrointestinal Disorders
#13864AVERMECTIN COMPOUNDS AND TREATMENT OF DERMATOLOGICAL DISORDERS THEREWITH
#13865Nutritional compositions
#13866Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#13867ACTIVE PACKAGING THAT INHIBITS FOOD PATHOGENS
#13868Nutritional weight loss agent and method
#13869Composition for relieving subjective symptoms of fatigue
#13870PHARMACEUTICAL COMPOSITION FOR TREATING DEPRESSION AND METHOD FOR PREPARATION THEREOF
#13871Composition for the Control of Cholesterol Levels
#13872Method for determining physiological effects of hemoglobin
#13873Compositions and methods for treatment of esophageal cancer
#13874Treatment methods and compositions for lung cancer, adenocarcinoma, and other medical conditions
#13875Pharmaceutical Compositions Useful in the Treatment of Migraine
#13876Composition and method for treatment of the side-effects associated with administration of cancer chemotherapeutic agents
#13877In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide and platinum catalyst
#13878In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide
#13879TREATMENT OF LAMINITIS
#13880Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative
#13881METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#13882Composition for delivery of hematopoietic growth factor
#13883Methods and compositions for treating inflammatory conditions
#13884Methods of using IGFIR and ABL kinase modulators
#13885Compositions and methods of use of compounds to increase cancer patient survival time
#13886METHODS OF INHIBITING RECEPTOR TYROSINE KINASES WITH AN EXTRACELLULAR ANTAGONIST AND AN INTRACELLULAR ANTAGONIST
#13887E1-MINUS ADENOVIRUSES AND USE THEREOF
#13888METHOD OF TREATING CANCER BY ADMINISTERING AN IMMUNOMODULATORY COMPOUND IN COMBINATION WITH A CD40 ANTIBODY OR CD40 LIGAND
#13889ANTIMICROBIAL CARBON
#13890Methods and compositions for tissue regeneration
#13891Kit of Lyophilized Thrombin and Lyophilized Fibrinogen Used to Compound Fibrin Membrane, and Its Application
#13892Compositions and use thereof for treating symptoms of preeclampsia
#13893HERBAL COMPOSITION FOR CANCER TREATMENT
#13894Cosmetic and/or dermatological composition for prevention and/or treatment of sensitive or dry skin
#13895ENDOTHELIAL PREDECESSOR CELL SEEDED WOUND HEALING SCAFFOLD
#13896Pharmaceutical composition for treatment of blood clotting disorder
#13897Methods for treating acute myeloid leukemia with diphtheria toxin-interleukin-3 conjugates
#13898Compositions for the acute and/or long term treatment of periodontal diseases
#13899Virucidal activities of cetylpyridinium chloride
#13900BILAYER PHARMACEUTICAL TABLET COMPRISING TELMISARTAN AND A DIURETIC AND PREPARATION THEREOF
#13901Compositions for Providing an Analgesic Effect to the Skin
#13902Novel NIDDM Regimen
#13903Methods and compositions for treating cancer
#13904Combination methods fo saha and targretin for treating cancer
#13905Method and Composition for the Treatment of Parkinson's Disease
#13906Pharmaceutical compositions comprising flavonoids and menthol
#13907Compositions and Methods for Perioperative Bladder Instillation
#13908Methods for the treatment of kidney disease
#13909PREVENTIVE AND/OR THERAPEUTIC AGENT FOR URINE COLLECTION DISORDER ACCOMPANYING LOWER URINARY TRACT OBSTRUCTION
#13910Methods to inhibit tumor cell growth by using proton pump inhibitors
#13911PHARMACEUTICAL COMPOSITION COMPRISING, IN COMBINATION, SAREDUTANT AND A SELECTIVE SEROTONIN REUPTAKE INHIBITOR OR A SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITOR
#13912Combination of a Selective Noradrenaline Reuptake Unhibitor and a PDEV Inhibitor
#13913Glucocorticoid receptor agonists
#13914PHARMACEUTICAL COMPOSITION OF DROSPIRENONE AND ETHYNYLESTRADIOL
#13915Pharmaceutical Composition Comprising the Combination of a Ketorolac Salt and Vitamins of the-B-Complex for the Treatment of Neuralgia
#13916Combination treatment for bladder cancer
#13917USE OF COMPATIBLE SOLUTES AS SUBSTANCES HAVING FREE RADICAL SCAVENGING PROPERTIES
#13918METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING DISTAL BOWEL LESIONS
#13919METHODS AND COMPOSITIONS FOR TREATING LESIONS OF THE RESPIRATORY EPITHELIUM
#13920Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#13921Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#13922COMBINED DRUG FOR TREATING DIABETES
#13923TREATMENT OF NEUROLOGICAL CONDITIONS USING COMPLEMENT C5a RECEPTOR MODULATORS
#13924Antitumoral Treatments
#13925Methods of stimulating bone growth using ZVEGF4 polypeptides
#13926Chimeric adenoviruses for use in cancer treatment
#13927Pharmaceutical composition for prevention and/or treatment of bone loss
#13928ORGANIC COMPOSITIONS AND METHODS OF USE
#13929METHOD OF PREVENTING, CONTROLLING AND AMELIORATING URINARY TRACT INFECTIONS USING A SYNERGISTIC CRANBERRY DERIVATIVE AND D-MANNOSE COMPOSITION
#13930Anti-glycation methods and compositions
#13931Pharmaceutical Compound For Treating Inflammation, Pain, Arthritis And Spinitis, And Proliferating Osteoblastic Cell And Method For Producing Thereof
#13932AGENT FOR THE THERAPY AND PROPHYLAXIS OF DIABETES MELLITUS
#13933Methods and compositions for treating feline hyperthyroidism
#13934Treatment of ovarian cancer
#13935ANTICANCER OR ANTIVIRAL COMPOSITION
#13936METHODS AND MATERIALS RELATING TO ENHANCED PRODUCTION OF DOPAMINE NEURONS
#13937Particulate-stabilized injectable pharmacutical compositions of posaconazole
#13938NANOPARTICLES OF A HETEROCRYSTAL MINERAL FOR USE AS A MEDICAMENT AND METHOD OF PRODUCING THE SAME
#13939(MONITORING ONLY) COMBINATIONS OF HMG-COA REDUCTASE INHIBITORS AND NICOTINIC ACID COMPOUNDS AND METHODS FOR TREATING HYPELIPIDEMIA ONCE A DAY AT NIGHT
#13940PHARMACEUTICAL COMPOSITIONS OF ATORVASTATIN
#13941Methods And Materials For Immunization Against Cancer
#13942HYDROXIDE-RELEASING AGENTS AS SKIN PERMEATION ENHANCERS
#13943PATHOGEN - CONTROLLING PRODUCTS
#13944SUPER BROWN CREAM
#13945Herbal composition for treatment of insomnia and other related disorders and a method of preparing the same
#13946Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the CNS
#13947Sphingosine 1-phosphate antagonism
#13948COMBINATION THERAPY WITH C-MET AND EGFR ANTAGONISTS
#13949ACTIVIN RECEPTOR-LIKE KINASE-1 COMPOSITIONS AND METHODS OF USE
#13950METHOD FOR TREATING DEMENTIA OR ALZHEIMER'S DISEASE
#13951Antibodies That Immunospecifically Bind to TRAIL Receptors
#13952Method for treating inflammation
#13953Subdermal tissue remodeling using myostatin, methods and related systems
#13954Chemical inhibitors of inhibitors of differentiation
#13955Food Products Comprising Probiotic Micro-Organisms and Antibodies
#13956Method for detecting infectious parvovirus in pharmaceutical preparations
#13957Pharmaceutical compositions comprising SODs and prolamine based peptide fragments
#13958ANTI-FATIGUE COMPOSITION
#13959Methods of treating vascular diseases characterized by nitric oxide insufficiency
#13960MEDICAMENTS COMPRISING GENE RECOMBINANT ANTIBODY AGAINST GANGLIOSIDE GD3
#13961COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF IMPLANTATION FAILURE OR MISCARRIAGE IN RECIPIENTS OF ARTIFICIAL INSEMINATION
#13962ANTIMICROBIAL COMPOSITION CONTAINING TRICLOSAN AND AT LEAST ONE FUNCTIONALIZED HYDROCARBON
#13963Methods for using GEP, a chondrogenic growth factor and target in cartilage disorders
#13964COMPOSITIONS COMPRISING AN ANTI-CA125 ANTIBODY AND A CYTOTOXIC COMPOUND AND THEIR USE FOR THE TREATMENT OF CANCER
#13965SYSTEM AND METHOD FOR THE PREVENTION AND TREATMENT OF BACTERIAL AND FUNGAL INFECTIONS INCLUDING URINARY TRACT INFECTIONS (UTI) USING A HYPOHALOUS ACID COMPOSITION
#13966Mannose derivatives for killing tumor cells
#13967Nutraceutical compositions comprising epigallocatechin gallate and raspberry ketone
#13968CB2 receptors blocks accumulation of human hepatic myofibroblasts: a novel antifibrogenic pathway in the liver
#13969Combination of CXCR4 Antagonist and Morphogen to Increase Angiogenesis
#13970Organic Compounds
#13971Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea
#13972Pharmacological Treatment for Sleep Apnea
#13973COMBINATIONS OF METFORMIN AND MEGLITINIDE
#13974COMPOSITIONS FOR TREATMENT OF COGNITIVE DISORDERS
#13975Compositions and methods for treatment of prostate and breast cancer
#13976COMBINATION ANTI-CANCER AGENTS
#13977Compositions and Methods for Treating Cognitive Disorders
#13978Uses of 2-Phenyl-Substituted Imidazotriazinone Derivatives for Treating Pulmonary Hypertension
#13979METHOD OF TREATING COGNITIVE IMPAIRMENT
#13980Compositions for treatment of systemic mastocytosis
#13981METHODS OF TREATING MULTIPLE SCLEROSIS BY ADMINISTERING PULSE DOSE CALCITRIOL
#13982Therapeutic micro nutrient composition for lipolysis and sclerosis
#13983NGNA compositions and methods of use
#13984Systemic purine administration: modulating axonal outgrowth of central nervous system neurons
#13985COMBINATIONS OF RECEPTOR TYROSINE KINASE INHIBITOR WITH AN A1-ACIDIC GLYCOPROTEIN BINDING COMPOUND
#13986Vegetarian anabolic protein composition
#13987Immunodynamic complexes and methods for using and preparing such complexes
#13988Certain Compositions and Methods of Treatment
#13989METHOD FOR TREATING AND/OR PREVENTING INFECTIONS IN INFANTS DELIVERED VIA CAESAREAN SECTION
#13990Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof
#13991Method for treating transplant rejection
#13992Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent
#13993USE OF SOY KEFIR POWDER FOR REDUCING PAIN, BLOOD PRESSURE AND INFLAMMATION
#13994Preventing diseases in infants delivered via caesarean section
#13995NOVEL VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION INHIBITORS
#13996GRAPE SEED EXTRACT AND ITS CONSTITUENTS FOR USE AS CYP2A6 INHIBITORS
#13997Compositions comprising apocynin, ginkgo and ginger and uses thereof
#13998Herbal acne control composition, method of manufacturing the same and use thereof
#13999Method of treating parturient placental mammals in order to reduce maternal and/or uterine exhaustion
#14000Stable Oral Pharmaceutical Composition Containing Thyroid Hormone Receptor Agonists
#14001Combination of erythropoietin glycoisoforms
#14002PREPARATION FOR THE TREATMENT OF TINNITUS
#14003Pharmaceutical compositions comprising non-steroidal antiinflammatory drug, antipyretic-analgesic drug and proton pump inhibitor
#14004Triple drug combinations for psychiatric patients
#14005Simultaneous Delivery of Receptors and/or Co-Receptors for Growth Factor Stability and Activity
#14006Suramin and derivatives thereof as topical microbicide and contraceptive
#14007Osteogenic and anti-adipogenic oxysterols
#14008METHODS AND COMPOSITIONS FOR TREATMENT OF GRAFT REJECTION AND PROMOTION OF GRAFT SURVIVAL
#14009Neuroprotection of retinal ganglion cells
#14010Specific binding proteins and uses thereof
#14011INHIBITION OF EXTRACELLULAR SIGNAL-REGULATED KINASE 1/2 AS A TREATMENT FOR CARDIAC HYPERTROPHY AND HEART FAILURE
#14012Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
#14013Method and compositions for treating skin
#14014Pharmaceutical active substance
#14015Prevention of micronutrient deficiencies associated with common disabilities in the over 50 adult
#14016Specific CD4+CD25+ Regulatory T Cells for Haematopoietic Cell Transplantation and Immune Tolerance
#14017COMBINATIONS COMPRISING HCV PROTEASE INHIBITOR(S) AND HCV IRES INHIBITOR(S), AND METHODS OF TREATMENT RELATED THERETO
#14018Hydroxamates as therapeutic agents
#14019Enhancing stem cell mobilization
#14020Methods and compositions for wound healing
#14021Spray Composition for Topical Use for Treating and/or Preventing Herpes Simplex Labial Infections
#14022TIGHT JUNCTION MODULATING PEPTIDE COMPONENTS FOR ENHANCING MUCOSAL DELIVERY OF THERAPEUTIC AGENTS
#14023Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy
#14024Anti-inflammatory formulation
#14025Antioxidant Food Composition and Methods and Uses Thereof
#14026Antimicrobial compositions, products and methods employing same
#14027Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer
#14028COMPOSITIONS AND METHODS FOR AMELIORATING CACHEXIA
#140296-oxo-1,6-dihydropyridine derivatives as inhibitors of MEK and methods of use thereof
#14030Compositions and methods for effecting NADlevels using a nicotinamide phosphoribosyl transferase inhibitor
#14031Pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
#14032Methods for treating drug resistant cancer
#14033Method of treating chronic myelogenous leukemia cells
#14034USE OF A PYRAZOLE DERIVATIVE FOR PREPARING MEDICINAL PRODUCTS THAT ARE USEFUL IN THE PREVENTION AND TREATMENT OF DYSLIPIDAEMIAS AND OF DISEASES RELATED TO DYSLIPIDAEMIAS AND/OR TO OBESITY
#14035Use of Selective Chloride Channel Modulators to Treat Alcohol and/or Stimulant Substance Abuse
#14036HETEROCYCLIC COMPOUNDS AS INHIBITORS OF BETA-LACTAMASES
#14037Association of a sinus node If current inhibitor and a calcium inhibitor, and pharmaceutical compositions containing it
#14038PREVENTION AND TREATMENT OF AN INCREASE IN CARDIOVASCULAR RISK, ADVERSE CARDIOVASCULAR EVENTS, INFERTILITY, AND ADVERSE PSYCHOLOGICAL EFFECTS AFTER ANDROGEN OR GNRH ANALOGUE INTAKE
#14039Pharmaceutical Compositions - 2
#14040METHOD AND SYSTEM FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH NEBULIZED ANTICHOLINERGIC ADMINISTRATIONS
#14041THERAPY FOR THE PROPHYLAXIS OR TREATMENT OF ADVERSE BODY COMPOSITION CHANGES AND/OR DECREASED MUSCLE STRENGTH AFTER ANDROGEN OR GNRH ANALOGUE INTAKE
#14042COMBINATION OF COMPOUNDS, WHICH CAN BE USED IN THE TREATMENT OF RESPIRATORY DISEASES, ESPECIALLY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND ASTHMA
#14043Reduction of Side Effects From Aromatase Inhibitors Used for Treating Breast Cancer
#14044Polysaccharides compositions comprising fucans and galactans and their use to reduce extravasation and inflammation
#14045Carbohydrate composition for flat glucose response
#14046Pyrimidines, such as cytidine, in treatments for patients with biopolar disorder
#14047Enhancement of iron chelation therapy
#14048USE OF A POLYENE MACROLIDE ANTIFUNGAL AGENT IN COMBINATION WITH A GLYCOPEPTIDE ANTIBACTERIAL AGENT
#14049COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETES
#14050Recombinant gene of adenovirus vector and p53 gene for treating proliferative diseases
#14051Use of mutant Herpes Simplex Virus-2 for cancer therapy
#14052Composition and methods for weight loss in a subject
#14053Weight loss composition
#14054Herbal Formulation for the Prevention and Management of Diabetes Mellitus and Diabetic Micro-Vascular Complications
#14055METHOD FOR TREATING OCULAR DEMODEX
#14056Combination anticancer therapy and pharmaceutical compositions therefore
#14057Pharmaceutical dosage forms comprising an active ingredient combination of nifedipine and/or nisoldipine and an angiotensin II antagonist
#14058Inorganic sorbent copolymer
#14059Methods of Treating alcoholism and alcohol related disorders using combination drug therapy and swellable polymers
#14060AGENT FOR USE IN THE CASE OF DISORDERS OF BLOOD SUGAR METABOLISM, INCLUDING DIABETES
#14061Method for Cell Implantation
#14062Oral dosage forms including an antiplatelet agent and an enterically coated acid inhibitor
#14063Peptide mixtures with immunomodulatory activity
#14064Combination of a beta-glucan and an egf receptor antagonist for the treatment of cancer and infection
#14065Method of treating cd30 positive lymphomas
#14066B-CELL REDUCTION USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULES
#14067Use of complement inhibitors to treat ocular diseases
#14068KINESIN INHIBITORS
#14069Combination Of Anti-Madcam Antibody And Antifibrotic Caspase Inhibitor To Treat Liver Fibrosis
#14070DIGESTIBLE COMPOSITIONS OF INULIN FOR MANAGING BLOOD GLUCOSE LEVELS
#14071METHOD OF TREATING PREVENTING, INHIBITING OR REDUCING DAMAGE TO CARDIAC TISSUE
#14072Methods and compositions for topical treatment of medical conditions including wounds and inflammation
#14073GEL-BASED COSMETIC AND WOUND-HEALING FORMULATION AND METHOD
#14074VASCULAR ENDOTHELIAL GROWTH FACTOR-D (VEGF)-D AND FUNCTIONALLY FRAGMENTS THEREOF FOR BONE REPAIRING
#14075Cancer Vaccines and Therapeutic Methods
#14076ISOLATED STROMAL CELLS FOR USE IN THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM
#14077Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
#14078COMBINATION CHAPERONIN 10 AND BETA-INTERFERON THERAPY FOR MULTIPLE SCLEROSIS
#14079Eye-drop vaccine containing copolymer 1 for therapeutic immunization
#14080Methods and Compositions for the Treatment of Sepsis
#14081Localized insulin delivery for bone healing
#14082Methods of Alleviating Disorders and Their Associated Pain
#14083COMPOUNDS FOR FLAVIVIRIDAE TREATMENT
#14084METHODS AND COMPOSITIONS FOR THE PREPARATION AND USE OF TOXIN CONJUGATES
#14085Recombinant vector expressing MDR1 shRNA and thymidine kinase and use thereof
#14086METHOD OF DETECTING AND TREATING ALLOGENIC CELLS RESPONSIBLE FOR ENDOMETRIOSIS
#14087Tumor therapy with replication competent sindbis viral vectors
#14088USE OF NEUROPEPTIDE Y (NPY) AND AGONISTS AND ANTAGONISTS THEREOF FOR TISSUE REGENERATION
#14089Different Types Of Mineral Matter Containing Carbonate With Reduced Fossil Fuel Carbon Dioxide Emission On Breakdown, Together With Their Synthesis Process And Their Uses
#14090KIT FOR ADMINSTERING A THERAPEUTIC AGENT INTO TISSUE
#14091Apparatus for administering a therapeutic agent into tissue
#14092Lipotoxicity relieving agent
#14093Prevention of and countermeasures against viral infection
#14094Use of allymercaptocaptopril for treating or preventing obesity and obesity related diseases
#14095Topical combination therapy for treating acne
#14096FLUOROQUINOLONE DERIVATIVES FOR OPHTHALMIC APPLICATIONS
#14097Fused ring 4-oxopyrimidine derivative
#14098Heterocyclic inhibitors of MEK and methods of use thereof
#140996-ETHER/THIOETHER-PURINES AS TOPOISOMERASE II CATALYTIC INHIBITORS AND THEIR USE IN THERAPY
#14100Association of a sinus node if current inhibitor and a beta blocker